Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Gh Research Plc (GHRS)

Gh Research Plc (GHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 798,630
  • Shares Outstanding, K 52,028
  • Annual Sales, $ 0 K
  • Annual Income, $ -38,960 K
  • EBIT $ -57 M
  • EBITDA $ -57 M
  • 60-Month Beta 0.97
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.57

Options Overview Details

View History
  • Implied Volatility 188.91% (+5.65%)
  • Historical Volatility 72.92%
  • IV Percentile 40%
  • IV Rank 32.70%
  • IV High 341.52% on 12/31/24
  • IV Low 114.75% on 10/20/25
  • Expected Move (DTE 14) 4.25 (28.54%)
  • Put/Call Vol Ratio 1.57
  • Today's Volume 18
  • Volume Avg (30-Day) 119
  • Put/Call OI Ratio 2.26
  • Today's Open Interest 1,713
  • Open Int (30-Day) 6,097
  • Expected Range 10.64 to 19.14

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.29
  • Number of Estimates 3
  • High Estimate -0.22
  • Low Estimate -0.35
  • Prior Year -0.17
  • Growth Rate Est. (year over year) -70.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.44 +19.65%
on 11/07/25
15.86 -6.12%
on 12/05/25
+1.30 (+9.57%)
since 11/05/25
3-Month
11.83 +25.87%
on 09/12/25
15.86 -6.12%
on 12/05/25
+0.80 (+5.68%)
since 09/05/25
52-Week
6.72 +121.58%
on 12/20/24
20.50 -27.37%
on 02/03/25
+6.89 (+86.13%)
since 12/05/24

Most Recent Stories

More News
3 Biotech Stocks Wall Street Analysts Predict Will More Than Double

What makes analysts so bullish about these three names from the sector?

MEHCQ : 3.5000 (-2.78%)
GHRS : 14.89 (-3.00%)
TYRA : 21.50 (-2.76%)
DMAC : 8.78 (+1.74%)
XBI : 123.41 (+0.13%)
These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week

These five small-cap pharma and biotech stocks drew heavy attention on Stocktwits last week, driven by key trial results, FDA updates, and promising drug developments.

MBX : 31.97 (+4.68%)
GHRS : 14.89 (-3.00%)
IVVD : 2.23 (+0.45%)
RANI : 1.5900 (+1.27%)
LIPO : 0.3090 (unch)
3 Fast-Growing Stocks Analysts See Doubling in Price

Clinical-stage biotech firms often have massive upside potential, but much of that possible success hinges on successful trials and product launches.

IMCR : 38.78 (-3.57%)
GHRS : 14.89 (-3.00%)
NTLA : 9.61 (-1.33%)
GH Research Reports First Quarter 2022 Financial Results and Provides Business Updates

DUBLIN, Ireland, May 18, 2022 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming...

GHRS : 14.89 (-3.00%)
GH Research Reports Full Year 2021 Financial Results and Provides Business Updates

DUBLIN, Ireland., March 28, 2022 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming...

GHRS : 14.89 (-3.00%)
Fighting Back Against the Mental Health Crisis with Outside-the-Box Thinking and Therapeutics

USA News Group – Before the global health crisis began at the beginning of 2020, 1 in 5 adults were receiving mental health treatment. As society emerges from the last two and a half years of disruptions,...

GHRS : 14.89 (-3.00%)
MOOD.CN : 0.6800 (unch)
JNJ : 201.93 (-0.27%)
MNMD : 12.35 (-0.64%)
CYBN : 5.99 (+0.67%)
Psychedelic Therapies Offer Hope for Mental Health

NetworkNewsWire Editorial Coverage : Neural plasticity is instrumental in brain health, and the importance of neuroplasticity can’t be overstated. Indeed, the inability of the nervous system to change...

CMPS : 5.82 (+2.46%)
GHRS : 14.89 (-3.00%)
CYBN.NE : 8.3400 (+0.85%)
ATAI : 4.32 (-1.82%)
MMED.NE : 14.9000 (+9.48%)
MNMD : 12.35 (-0.64%)
CYBN : 5.99 (+0.67%)
Psychedelic Therapies Offer Hope for Mental Health

NetworkNewsWire Editorial Coverage   New York, NY – March 2, 2022 – Neural plasticity is instrumental in brain health, and the importance of neuroplasticity can’t be overstated. Indeed, the inability...

CMPS : 5.82 (+2.46%)
GHRS : 14.89 (-3.00%)
CYBN.NE : 8.3400 (+0.85%)
ATAI : 4.32 (-1.82%)
MMED.NE : 14.9000 (+9.48%)
MNMD : 12.35 (-0.64%)
CYBN : 5.99 (+0.67%)

Business Summary

GH Research PLC is a clinical-stage biopharmaceutical company. It dedicated to treat psychiatric and neurological disorders. The company's initial focus is on developing its novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment-Resistant Depression. GH Research PLC is...

See More

Key Turning Points

3rd Resistance Point 16.61
2nd Resistance Point 16.24
1st Resistance Point 15.56
Last Price 14.89
1st Support Level 14.51
2nd Support Level 14.14
3rd Support Level 13.46

See More

52-Week High 20.50
Fibonacci 61.8% 15.24
Last Price 14.89
Fibonacci 50% 13.61
Fibonacci 38.2% 11.98
52-Week Low 6.72

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar